Page last updated: 2024-08-16

rivastigmine and Neuroblastoma

rivastigmine has been researched along with Neuroblastoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Borges, F; Brunetti, L; Cardoso, SM; Chavarria, D; Chaves, S; Guedes, B; Madrid, Y; Piemontese, L; Santos, MA; Vicente-Zurdo, D1
Hamidi, M; Hosseini, MJ; Kaboli, Z; Manjili, HK; Rostamizadeh, K; Sadighian, S1
Ceruti, M; Giammona, G; Licciardi, M; Pitarresi, G; Rocco, F; Scialabba, C1
Arias, E; Gallego-Sandín, S; García, AG; López, MG; Villarroya, M1

Other Studies

4 other study(ies) available for rivastigmine and Neuroblastoma

ArticleYear
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases.
    International journal of molecular sciences, 2023, May-05, Volume: 24, Issue:9

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzimidazoles; Chelating Agents; Cholinesterase Inhibitors; Ferric Compounds; Humans; Monoamine Oxidase; Neuroblastoma; Neurodegenerative Diseases; Rivastigmine

2023
Valine conjugated polymeric nanocarriers for targeted co-delivery of rivastigmine and quercetin in rat model of Alzheimer disease.
    International journal of pharmaceutics, 2023, Oct-15, Volume: 645

    Topics: Alzheimer Disease; Animals; Drug Carriers; HEK293 Cells; Humans; Neuroblastoma; Polyesters; Polyethylene Glycols; Polymers; Quercetin; Rats; Rivastigmine

2023
Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells.
    Drug delivery, 2012, Volume: 19, Issue:6

    Topics: Animals; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Micelles; Neuroblastoma; Neurons; Neuroprotective Agents; Particle Size; Peptides; Phenylcarbamates; Rivastigmine; Spectrometry, Fluorescence

2012
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:3

    Topics: Aconitine; Amyloid beta-Peptides; Apoptosis; Benzopyrans; Cell Culture Techniques; Cell Line, Tumor; Cholinesterase Inhibitors; Chromones; Donepezil; Dose-Response Relationship, Drug; Enzyme Inhibitors; Galantamine; Humans; Indans; L-Lactate Dehydrogenase; Morpholines; Neuroblastoma; Neuroprotective Agents; Nicotine; Nitriles; Okadaic Acid; Phenylcarbamates; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Receptors, Nicotinic; Rivastigmine

2005